IM CANNABIS CORP.

Profile

Company Names

IM CANNABIS CORP.

Addresses

KIBBUTZ GLIL YAM, CENTRAL DISTRICT, L3 4690500

SUITE 2300, 550 BURRARD STREET, VANCOUVER, A1 V6C 2B5

Phone Numbers

416-256-4202

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$340,497.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-11-12 
$26,893.00 
$67,234.00 
$40,341.00 
Equity 
3
2020-06-26 
$302,077.00 
$302,077.00 
$0.00 
Equity 
2
2020-06-17 
$11,527.00 
$11,527.00 
$0.00 
Equity 
1
2019-10-11 
$0.00 
$3,221,811.00 
$3,221,811.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SHMULIK 
 
ARBEL 
DIRECTOR
IM CANNABIS CORP.
RICHARD 
 
BALLA 
EXECUTIVE OFFICER
IM CANNABIS CORP.
VIVIAN 
 
BERCOVICI 
DIRECTOR
IM CANNABIS CORP.
URI 
 
BIRENBERG 
EXECUTIVE OFFICER
IM CANNABIS CORP.
RAFAEL 
 
GABAY 
DIRECTOR
IM CANNABIS CORP.
AMIR 
 
GOLDSTEIN 
EXECUTIVE OFFICER
I.M.C. HOLDINGS LTD.   |  IM CANNABIS CORP.
YAEL 
 
HARROSH 
EXECUTIVE OFFICER
IM CANNABIS CORP.
JESSE 
 
KAPLAN 
DIRECTOR
ROCKSTAR CAPITAL CORP.   |  EHAVE, INC.   |  ABACUS HEALTH PRODUCTS, INC.   |  IM CANNABIS CORP.   |  NOVAMIND VENTURES INC.   |  NOVAMIND INC.
MARC 
 
LUSTIG 
DIRECTOR
TRICHOME FINANCIAL CORP.   |  CANNAROYALTY CORP.   |  RESOLVE DIGITAL HEALTH INC   |  IM CANNABIS CORP.   |  RPE INC.   |  CRESCO LABS INC.
MOTI 
 
MARCUS 
DIRECTOR
IM CANNABIS CORP.
STEVEN 
 
MINTZ 
DIRECTOR
BROWNSTONE VENTURES INC   |  CARLISLE GOLDFIELDS LTD   |  IM CANNABIS (FINANCE) LTD.   |  IM CANNABIS CORP.   |  PORTAGE BIOTECH INC.   |  ALPHATON CAPITAL CORP
MICHAL LEBOVITZ 
 
NISSIMOV 
EXECUTIVE OFFICER
IM CANNABIS CORP.
BRIAN 
 
SCHINDERLE 
DIRECTOR
IM CANNABIS CORP.
SHAI 
 
SHEMESH 
EXECUTIVE OFFICER
IM CANNABIS CORP.
OREN 
 
SHUSTER 
EXECUTIVE OFFICER, DIRECTOR
I.M.C. HOLDINGS LTD.   |  IM CANNABIS CORP.
EINAT 
 
ZAKARIYA 
DIRECTOR
IM CANNABIS CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-11-20
D
Link
PHARMACEUTICALS 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2024-11-12 
2020-07-09
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-17 
2020-07-09
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-26 
2019-10-24
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2019-10-11 
2019-10-24
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2019-10-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#